Robert M. Anderson Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
PhD Student
grad_student
Research Areas
Biography and Research Information
OverviewAI-generated summary
Robert M. Anderson's research focuses on the economic evaluation of health interventions, particularly in the areas of dementia and infectious diseases. He has published on the epidemiological, physical, psychological, and economic costs associated with early pregnancy loss. His work includes systematic reviews and cost-effectiveness modeling for dementia risk factors, with studies examining interventions for dementia prevention and the economic modeling of these benefits in specific populations, such as England.
Anderson has also investigated the economic aspects of vaccination programs, including a systematic review of economic evaluations for varicella vaccination. His research extends to estimating the costs of visual impairment in individuals with diabetes in India and evaluating screening programs for diabetic retinopathy in public health systems. His scholarship metrics include an h-index of 55, 218 total publications, and over 14,000 citations, designating him as a highly cited researcher. He leads a research group and maintains an active lab website.
Metrics
- h-index: 55
- Publications: 218
- Citations: 14,352
Selected Publications
-
<p>The Evolution of the Poison Pill</p> (2025)
-
<p><span>Contracting For Maritime Liens: A Survey Of Marine Fuel Sale Agreements</span></p> (2025)
-
Proposed Brief of Current and Retired Practitioners and Professors as Amici Curiae in Support of Reversal in In re Tesla, Inc. Derivative Litigation (2025)
Collaboration Network
Top Collaborators
- Benefits of population-level interventions for dementia risk factors: an economic modelling study for England
- Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
- Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system
- Costs and cost-effectiveness of the Kerala Pilot Screening Programme for Diabetic Retinopathy in the public health system
- Benefits of population‐level interventions for dementia risk factors: an economic modelling study
- On Existence of Berk-Nash Equilibria in Misspecified Markov Decision Processes with Infinite Spaces
- THE SECOND WELFARE THEOREM FOR QUOTA EQUILIBRIUM
- <div> Existence of Equilibria in Large Competitive Markets with&nbsp;<span>Bads, Production and Comprehensive Externalities</span></div>
- PARETO OPTIMALITY WITH EXTERNALITIES
- B-PO05-121 THE FINAL FRONTIER IN CARDIAC MAPPING: INTRA-MURAL MYOCARDIAL MAPPING USING INDEX OF ACTIVATION ON MAPPING GRID
- Clinical significance of conduction velocity orientation vectors on cardiac mapping surfaces
- Principal Component–Referenced Multipolar Mapping to Localize an Arrhythmic Source From Various Depths of the Myocardium
- B-PO05-121 THE FINAL FRONTIER IN CARDIAC MAPPING: INTRA-MURAL MYOCARDIAL MAPPING USING INDEX OF ACTIVATION ON MAPPING GRID
- Clinical significance of conduction velocity orientation vectors on cardiac mapping surfaces
- Principal Component–Referenced Multipolar Mapping to Localize an Arrhythmic Source From Various Depths of the Myocardium
- A systematic review of the cost-effectiveness of community and population interventions to reduce the modifiable risk factors for dementia
- Benefits of population-level interventions for dementia risk factors: an economic modelling study for England
- Benefits of population‐level interventions for dementia risk factors: an economic modelling study
- A systematic review of the cost-effectiveness of community and population interventions to reduce the modifiable risk factors for dementia
- Benefits of population-level interventions for dementia risk factors: an economic modelling study for England
- Benefits of population‐level interventions for dementia risk factors: an economic modelling study
- A systematic review of the cost-effectiveness of community and population interventions to reduce the modifiable risk factors for dementia
- Benefits of population-level interventions for dementia risk factors: an economic modelling study for England
- Benefits of population‐level interventions for dementia risk factors: an economic modelling study
- A systematic review of the cost-effectiveness of community and population interventions to reduce the modifiable risk factors for dementia
- Benefits of population-level interventions for dementia risk factors: an economic modelling study for England
- Benefits of population‐level interventions for dementia risk factors: an economic modelling study
- Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
- Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system
- Costs and cost-effectiveness of the Kerala Pilot Screening Programme for Diabetic Retinopathy in the public health system
- Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
- Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system
- Costs and cost-effectiveness of the Kerala Pilot Screening Programme for Diabetic Retinopathy in the public health system
- Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss
- Systematic review of economic evaluations of varicella vaccination programmes
- B-PO05-121 THE FINAL FRONTIER IN CARDIAC MAPPING: INTRA-MURAL MYOCARDIAL MAPPING USING INDEX OF ACTIVATION ON MAPPING GRID
- Clinical significance of conduction velocity orientation vectors on cardiac mapping surfaces
- B-PO05-121 THE FINAL FRONTIER IN CARDIAC MAPPING: INTRA-MURAL MYOCARDIAL MAPPING USING INDEX OF ACTIVATION ON MAPPING GRID
- Clinical significance of conduction velocity orientation vectors on cardiac mapping surfaces
- Cost‐effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross‐comparison challenge
- IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease
- Cost‐effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross‐comparison challenge
- IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease
Similar Researchers
Based on overlapping research topics